Clinuvel Pharmaceuticals Ltd has released a press release.
Media Release - CLINUVEL expands DNA Repair Program
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Story so far
Earlier from Clinuvel Pharmaceuticals
- Appendix 4D Half Yearly Report
- CLINUVEL Strategic Update - Extended
- Media Release - CLINUVEL to Trial Innovative Drug in Stroke
- Australian TGA approves SCENESSE
- Trading Halt
Later from Clinuvel Pharmaceuticals
- Appendix 4C - quarterly
- Appendix 4E and Preliminary Financial Report
- CLINUVEL Delivers Record Revenues and Profit
- Response to ASX Price Query
- Appendix 4D Half Year Report
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals